Inogen Inc Stock Investor Sentiment

INGN Stock  USD 7.45  0.43  5.46%   
About 62% of Inogen's investor base is looking to short. The analysis of overall sentiment of trading Inogen Inc stock suggests that many investors are alarmed at this time. Inogen's investing sentiment overview a quick insight into current market opportunities from investing in Inogen Inc. Many technical investors use Inogen Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

Inogen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Inogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Inogen Maximum Pain Price Across June 20th 2025 Option Contracts

Inogen's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Inogen close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Inogen's options.
a minute ago at finance.yahoo.com         
Inogen Announces Third Quarter 2024 Financial Results
Yahoo News
21 hours ago at thelincolnianonline.com         
Insider Trading
news
a day ago at www.macroaxis.com         
Disposition of 13700 shares by Kevin Smith of Inogen at 8.33 subject to Rule 16b-3
Macroaxis News
3 days ago at zacks.com         
Inogen Q4 Earnings Taking a Look at Key Metrics Versus Estimates
zacks News
3 days ago at finance.yahoo.com         
Inogen Q4 Earnings Taking a Look at Key Metrics Versus Estimates
Yahoo News
few days ago at finance.yahoo.com         
Heres Why You Should Retain Inogen Stock in Your Portfolio Now
Yahoo News
over a week ago at simplywall.st         
Why Investors Shouldnt Be Surprised By Inogen, Inc.s 35 percent Share Price Plunge
Simply Wall St News at Macroaxis
over a week ago at www.macroaxis.com         
Acquisition by Glezer Stanislav of 43993 shares of Inogen subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
Insider Buying Michael Bourque Acquires Shares of Inogen Inc
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Insider Buying Smith Kevin Raymond Merrill Acquires Shares of Inogen Inc
Gurufocus Stories at Macroaxis
over a week ago at kalkinemedia.com         
Acquisition by Michael Bourque of 25000 shares of Inogen subject to Rule 16b-3
news
over a week ago at kalkinemedia.com         
Medical Oxygen Systems Market Is Booming Worldwide 2025-2032 Koninklijke Philips N.V, Inogen, Inc., ...
news
over a week ago at www.macroaxis.com         
Acquisition by Kevin Smith of 11709 shares of Inogen at 8.5614 subject to Rule 16b-3
Macroaxis News
over two weeks ago at thelincolnianonline.com         
Acquisition by Kevin Smith of 1500 shares of Inogen at 8.33 subject to Rule 16b-3
news
over two weeks ago at thelincolnianonline.com         
Inogen Cut to Hold at StockNews.com
news
Far too much social signal, news, headlines, and media speculation about Inogen that are available to investors today. That information is available publicly through Inogen media outlets and privately through word of mouth or via Inogen internal channels. However, regardless of the origin, that massive amount of Inogen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Inogen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Inogen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Inogen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Inogen alpha.

Inogen Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Inogen, Inc. announced that it expects to receive 27.209763 million in funding -January 24, 2025 - Marketscreener.com
01/24/2025
2
Heres Why You Should Add Inogen Stock to Your Portfolio Now
02/06/2025
3
Disposition of 2117 shares by Nabil Shabshab of Inogen subject to Rule 16b-3
02/21/2025
4
The Zacks Analyst Blog Highlights Fresenius Medical, Masimo, Merit Medical Systems and Inogen
02/25/2025
5
Inogen Inc Q4 2024 Earnings Call Highlights Revenue Growth and Strategic Partnerships ...
02/26/2025
6
Inogen Full Year 2024 Earnings Beats Expectations
02/27/2025
7
Needham Company LLC Reaffirms Hold Rating for Inogen
02/28/2025
8
Acquisition by Kevin Smith of 11709 shares of Inogen at 8.5614 subject to Rule 16b-3
03/03/2025
9
Medical Oxygen Systems Market Is Booming Worldwide 2025-2032 Koninklijke Philips N.V, Inogen, Inc., BOC Healthcare
03/04/2025
10
Acquisition by Glezer Stanislav of 43993 shares of Inogen subject to Rule 16b-3
03/06/2025
11
Inogen Q4 Earnings Taking a Look at Key Metrics Versus Estimates
03/13/2025
12
Disposition of 13700 shares by Kevin Smith of Inogen at 8.33 subject to Rule 16b-3
03/14/2025
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out Inogen Hype Analysis, Inogen Correlation and Inogen Performance.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.873
Earnings Share
(1.52)
Revenue Per Share
14.192
Quarterly Revenue Growth
0.055
Return On Assets
(0.08)
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.